New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
11:23 EDTCOV, RVBD, BG, TWX, KORSOptions with increasing implied volatility
Options with increasing implied volatility: KORS TWX RVBD KORS BG COV
News For TWX;RVBD;KORS;BG;COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
07:19 EDTKORSMichael Kors holiday catalog pricing up 11%, says Piper Jaffray
Piper Jaffray says its analysis shows the weighted average pricing for the Michael Kors Holiday catalog was $242, up 11% from last year. The firm adds the catalog contains new handbag silhouettes introductions including Dillon & Sutton. Piper continues to view Michael Kors as its top Holiday pick and keeps an Overweight rating on the name with a $98 price target.
05:14 EDTCOVCovidien achieves CE Mark for Nellcor Bedside SpO2 Patient Monitoring System
Subscribe for More Information
November 19, 2014
08:15 EDTCOVMedtronic reported solid Q2 results, says Bernstein
Bernstein notes that Medtronic's (MDT) sales growth accelerated to 5%, and the firm thinks the company's market share of the ICD market is poised to increase next quarter. Bernstein views Medtronic as "a strong buy" into the close of its acquisition of Covidien (COV). The firm reiterates an Outperform rating on Medtronic.
06:54 EDTCOVMedtronic reiterated as a top pick at JPMorgan
Subscribe for More Information
November 18, 2014
12:08 EDTCOVOn The Fly: Midday Wrap
Subscribe for More Information
09:08 EDTCOVMedtronic says regulatory processes for Covidien deal 'all on track'
Subscribe for More Information
07:36 EDTRVBDUBS to hold a conference
Global Technology Conference to be held in Sausalito, California on November 18-20 with webcasted company presentations to begin on November 18 at 10:45 am; not all company presentations may be webcasted. Webcast Link
07:30 EDTKORSMorgan Stanley to hold a conference
Subscribe for More Information
07:20 EDTCOVMedtronic confirms commitment to Covidien transaction
Subscribe for More Information
November 17, 2014
11:24 EDTRVBDRiverbed turns positive after confidentiality pact with Elliott disclosed
Subscribe for More Information
11:20 EDTRVBDRiverbed signs confidentiality agreement with shareholder Elliott
Subscribe for More Information
06:33 EDTTWXWarner Bros. wins 'Hobbit' royalties fight against Weinsteins, WSJ reports
Time Warner's Warner Bros. has prevailed over the Weinstein brothers in a $75M-plus lawsuit over the royalties for the second and third "Hobbit" films, the Wall Street Journal reports, citing people with knowledge of the situation. Reference Link
November 14, 2014
17:27 EDTCOVPaulson & Co. gives quarterly update on stakes
Subscribe for More Information
12:43 EDTCOVMedtronic readying $10B bond sale for Covidien deal, WSJ reports
Subscribe for More Information
11:50 EDTCOVMedtronic readying $10B bond sale for Covidien deal, Dow reports
Subscribe for More Information
November 13, 2014
18:07 EDTCOVCovidien' VenaSeal closure system shows positive results
Covidien announced the six-month results of the VeClose pivotal study of the safety and effectiveness of the VenaSeal closure system in patients with chronic venous insufficiency having symptomatic reflux in the great saphenous vein. The VeClose randomized controlled non-inferiority study compared the safety and effectiveness of the VenaSeal system to that of the ClosureFast endovenous radiofrequency ablation catheter. Covidien's ClosureFast catheter is an endovenous radiofrequency ablation catheter designed to collapse and close enlarged leg veins. The VenaSeal system is not approved and currently limited to investigational use in the U.S. At three months, the complete closure of the great saphenous veins achieved in more than 98.9% of patients treated with the VenaSeal system compared to 95.6% of patients treated with the ClosureFast catheter. The closure rate at six months was 98.9% and 94.3%.
13:27 EDTCOVMedtronic likely to continue to make new highs, Barron's says
Subscribe for More Information
November 12, 2014
10:43 EDTTWXBernstein downgrades Discovery, Viacom, citing 'structural decline' in TV
Research firm Bernstein sees strong evidence that audiences of ad-supported TV have entered a period of "structural decline." The firm cut its rating on Discovery (DISCA), the owner of the Discovery Channel and Animal Planet cable stations, and Viacom (VIA,VIAB), which owns MTV and and Nickelodeon. The firm also cut its price target on CBS (CBS). WHAT'S NEW: Noting that audiences for ad-supported TV have fallen by unprecedented amounts for four months, Bernstein analyst Todd Juenger added that consumption of subscription video on demand, or SVOD, services continue to grow. Meanwhile, TV networks are seeing increased competition from Internet websites for ad dollars, limiting the ability of the networks to raise ad prices, Juenger stated. The profit margins and return on investment of content owners are likely to decline over time, the analyst believes. He downgraded Discovery to Market Perform from Outperform and set a $37 price target on the stock, and cut Viacom to Underperform from Market Perform, placing a $71 price target on that stock. Juenger reduced his price target on CBS to $55 from $60 and kept a Market Perform rating on the shares. He kept Outperform ratings on 21st Century Fox (FOXA), Disney (DIS), and Time Warner (TWX), saying that those are least affected by the trend, as they are less dependent than their peers on the American TV ad market and have a large amount of sports programming. PRICE ACTION: In mid-morning trading, Discovery lost 0.6% to $31.81, Viacom class A shares gained 0.6% to $70.09, CBS fell 0.7% to $51.48, Twenty-First Century Fox class A shares lost 0.5% to $34.75, Time Warner fell 0.5% to $77.69 and Disney was flat near $90 per share.
07:58 EDTKORSFossil price target raised to $150 from $140 at Jefferies
Jefferies raised its price target for Fossil (FOSL) shares to $150 saying the company's renewed agreement with Michael Kors (KORS) removes an overhang on the stock. The firm thinks Fossil's European growth potential associated with the Kors relationship is underappreciated. It reiterates a Buy rating on the stock.
06:22 EDTTWXFunny or Die hires Moelis to explore potential sale, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use